about
Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cellsThe translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesisGene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinomaTranscriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue.A novel regulatory event-based gene set analysis method for exploring global functional changes in heterogeneous genomic data sets.Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma.p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virusCommon telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.Integration of hepatitis B virus DNA into chromosomal DNA during acute hepatitis BHepatocellular carcinoma: are we making progress?Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivationCodon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore.The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene.The molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma.Modulation of apoptotic signaling by the hepatitis B virus X protein.Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell linesRegulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis.Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma.Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.HBx-DNA probe preparation and its application in study of hepatocarcinogenesis.Heterogeneous kinetics of AKT signaling in individual cells are accounted for by variable protein concentration.Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States.Distinctive gene expression profiles associated with Hepatitis B virus x protein.Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.Gene delivery using a receptor-mediated gene transfer system targeted to hepatocellular carcinoma cells.A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway.Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes.Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas.Modulation of glutathione S-transferase alpha by hepatitis B virus and the chemopreventive drug oltipraz.Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors.Molecular and cellular pathology of hepatocellular carcinoma.Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.
P2860
Q27478479-47D9A2B6-FC75-4A34-9F68-CDD7E42A5304Q28141874-86E1C3F8-AB62-4C8B-8723-028998E36A4FQ28740309-72B00C9C-1A36-4F07-A698-1B0C79EF7126Q30661634-37E6CF00-1519-45FD-B77E-E8505338B493Q33400135-84BE4BDD-26E1-4DBA-9501-42423AE52644Q33706203-39D5E209-9BA5-4417-9C90-FAC1794161F5Q34609247-7A9F666D-EF77-48E0-8BFC-056A65AB2A61Q34827556-DF72E63B-D8EB-4444-930A-8FD0CC4D86DBQ35165944-9F68AED1-17C7-4243-8FAF-A712C0A0FB2CQ35193283-CB09C537-E775-46F0-BE5F-63E0BE8EF5CCQ35835238-F8881426-A5E5-4336-9E8A-DFBCB5336257Q36081903-7713ED4D-8EF2-4AAF-B0ED-0B27DB44E99AQ36134953-7FED2B8C-F7B1-4EBA-9675-237E0FF698F4Q36419017-0D6A9781-9755-4188-8E5A-F173AB86F250Q36432730-204B2A7C-B3C2-4687-87A0-56F4065B7ADCQ36830710-470AA6E6-309C-4F93-8722-759AD83AF8EDQ36846983-113A9790-178E-4084-963E-C2877228E848Q37068909-AA63C4F1-7CD1-4741-94B3-76F64F6A87C5Q37350292-9B4CD8E4-D223-4778-A83D-F0E72D238F20Q37662166-C87DF20D-5CD4-4D7D-AD21-46325D9154ABQ37777019-F091C12D-EDC2-48BD-8BCE-B301C293BC01Q38110262-B065C350-5AD7-4771-9217-5D8E54586232Q38500276-27E19659-A25D-4908-86C3-972B8CB16877Q38578043-08987541-6AFB-4578-AABF-FDF343A8FC32Q39229234-C516C73B-E5D6-4280-B204-61ECFBABD811Q39486033-3548B81D-118D-4274-A458-D01C0642CA2CQ40603466-DB7C16B8-D0A2-49C3-872A-801B921E9335Q40794517-3619E1BA-BF69-4AB1-A4F1-6D8DC0534E4EQ40794530-CCD92795-FD6A-47EE-AD50-A7D94AA55625Q40795424-27C526F6-3F93-4093-8564-3498B2B7D718Q42986473-D368017D-A0CC-4D6A-A20B-DE43CCB52DE6Q43565298-1B044C74-9AF8-4B53-A147-7D546FBCBF63Q43601401-0B2C8A29-2079-414B-900D-C13206835AF5Q43857388-5804AB14-579B-4069-835F-1014126206ABQ45741117-12C455A3-D7D0-4970-9953-DA0F60D75C45Q45747173-5F83CE87-7CFA-456A-8DE3-CFC1FE320502Q46892912-D96E45AB-B6B2-4D6C-9442-841820B287A5Q47672601-273FCF8D-12D8-4FB5-B72D-E8AF03FE642FQ47745588-59D3C6DD-045D-409F-9291-4686E08A97B7Q52834192-7A262FCA-03D1-4823-AD60-C9E88846247D
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Genetic heterogeneity of hepatocellular carcinoma
@ast
Genetic heterogeneity of hepatocellular carcinoma
@en
type
label
Genetic heterogeneity of hepatocellular carcinoma
@ast
Genetic heterogeneity of hepatocellular carcinoma
@en
prefLabel
Genetic heterogeneity of hepatocellular carcinoma
@ast
Genetic heterogeneity of hepatocellular carcinoma
@en
P2093
P2860
P356
P1476
Genetic heterogeneity of hepatocellular carcinoma
@en
P2093
C Yakicier
H Zentgraf
K J Isselbacher
M Volkmann
P2860
P304
P356
10.1073/PNAS.91.2.822
P407
P577
1994-01-01T00:00:00Z